Sector News

Linde buys U.S.-based respiratory therapies specialist

December 7, 2015
Chemical Value Chain

(Reuters) – German industrial gases maker Linde (LING.DE) said on Monday it agreed to acquire U.S.-based respiratory therapies specialist American HomePatient [HIAAMA.UL] from Highland Capital Management LP.

No financial details were disclosed.

The deal is expected to close in the first quarter of 2016.

American HomePatient had sales of about 260 million euros ($282 million) in the last financial year.

($1 = 0.9231 euros)

(Reporting by Christoph Steitz; Editing by James Regan)

Related News

June 13, 2021

Husky Injection Molding Systems teams up with Chem-Trend to slash color change times

Chemical Value Chain

Industrial technology provider Husky Injection Molding Systems is partnering with injection molding specialist Chem-Trend to design a color change system for packaging manufacturers to ensure repeatability and a more optimized and accurate process.

June 13, 2021

MOL Group to acquire OMV’s business in Slovenia

Chemical Value Chain

The agreement encompasses 120 filling stations, as well as OMV’s wholesale business in Slovenia. The transaction is subject to required regulatory approvals and closing is expected in 2022.

June 13, 2021

The biodegradable battery – an ecological miracle

Chemical Value Chain

Xavier Aeby and Gustav Nyström from Empa’s Cellulose & Wood Materials lab invented a fully printed biodegradable battery made from cellulose and other non-toxic components.

Send this to a friend